TRANSPLANT Act of 2020
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Sep 23, 2020)
Timely ReAuthorization of Necessary Stem-cell Programs Lends Access to Needed Therapies Act of 2020 or the TRANSPLANT Act of 2020
This bill modifies and reauthorizes through FY2025 the C.W. Bill Young Cell Transplantation Program, which provides support to patients who need a potentially life-saving bone marrow transplant or umbilical cord blood transplant. It also requires research and other activities related to stem cell therapies.
Specifically, the Department of Health and Human Services must conduct a periodic review of the science of using adult stem cells and birthing tissues in therapeutic treatments, and the National Institutes of Health must continue efforts to further the field of regenerative medicine using adult stem cells.
In addition, the Government Accountability Office must examine various issues related to the national blood stem cell workforce.
What just happenedSep 23, 2020
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835)
Who’s behind it
- Introduced in SenateSep 23, 2020
- Sep 23, 2020IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S5835)
Health, Education, Labor, and Pensions Committee - Sep 23, 2020IntroReferral10000
Introduced in Senate